PGNY
Income statement / Annual
Last year (2025), Progyny Inc's total revenue was $1.29 B,
an increase of 10.40% from the previous year.
In 2025, Progyny Inc's net income was $58.52 M.
See Progyny Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$1.29 B |
$1.17 B |
$1.09 B |
$786.91 M |
$500.62 M |
$344.86 M |
$229.68 M |
$105.40 M |
$48.58 M |
| Cost of Revenue |
$984.18 M
|
$913.86 M
|
$849.80 M
|
$619.59 M
|
$388.49 M
|
$274.80 M
|
$184.18 M
|
$85.97 M
|
$41.18 M
|
| Gross Profit |
$304.48 M
|
$253.36 M
|
$238.80 M
|
$167.33 M
|
$112.14 M
|
$70.06 M
|
$45.51 M
|
$19.43 M
|
$7.40 M
|
| Gross Profit Ratio |
0.24
|
0.22
|
0.22
|
0.21
|
0.22
|
0.2
|
0.2
|
0.18
|
0.15
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$147.09 M
|
$121.96 M
|
$117.13 M
|
$98.33 M
|
$59.62 M
|
$46.71 M
|
$23.93 M
|
$15.60 M
|
$14.15 M
|
| Selling & Marketing Expenses |
$72.11 M
|
$63.95 M
|
$59.49 M
|
$45.66 M
|
$20.18 M
|
$15.01 M
|
$11.90 M
|
$7.29 M
|
$4.26 M
|
| Selling, General & Administrative Expenses |
$219.21 M
|
$185.91 M
|
$176.62 M
|
$143.98 M
|
$79.80 M
|
$61.71 M
|
$35.83 M
|
$22.89 M
|
$18.41 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$219.21 M
|
$185.91 M
|
$176.62 M
|
$143.98 M
|
$79.80 M
|
$61.71 M
|
$35.83 M
|
$22.89 M
|
$18.41 M
|
| Cost And Expenses |
$1.20 B
|
$1.10 B
|
$1.03 B
|
$763.57 M
|
$468.28 M
|
$336.51 M
|
$220.01 M
|
$108.85 M
|
$59.59 M
|
| Interest Income |
$0.00
|
$15.75 M
|
$8.51 M
|
$814.00 K
|
$461.00 K
|
$121.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$58.00 K
|
$497.00 K
|
$740.00 K
|
| Depreciation & Amortization |
$4.95 M
|
$3.18 M
|
$2.28 M
|
$1.60 M
|
$1.30 M
|
$1.91 M
|
$2.13 M
|
$1.88 M
|
$1.56 M
|
| EBITDA |
$100.38 M |
$70.63 M |
$64.47 M |
$24.94 M |
$33.64 M |
$10.25 M |
$11.81 M |
-$1.57 M |
-$9.45 M |
| EBITDA Ratio |
0.08
|
0.06
|
0.06
|
0.03
|
0.07
|
0.03
|
0.05
|
-0.01
|
-0.19
|
| Operating Income Ratio |
0.07
|
0.06
|
0.06
|
0.03
|
0.06
|
0.02
|
0.04
|
-0.03
|
-0.23
|
| Total Other Income/Expenses Net |
$10.16 M
|
$15.75 M
|
$8.51 M
|
$1.10 M
|
$95.00 K
|
$331.00 K
|
-$18.23 M
|
-$3.44 M
|
-$1.45 M
|
| Income Before Tax |
$95.43 M
|
$83.20 M
|
$70.69 M
|
$24.44 M
|
$32.44 M
|
$8.68 M
|
-$8.56 M
|
-$6.89 M
|
-$12.46 M
|
| Income Before Tax Ratio |
0.07
|
0.07
|
0.06
|
0.03
|
0.06
|
0.03
|
-0.04
|
-0.07
|
-0.26
|
| Income Tax Expense |
$36.91 M
|
$28.87 M
|
$8.65 M
|
-$5.92 M
|
-$33.33 M
|
-$37.78 M
|
$12.00 K
|
-$1.78 M
|
-$3.00 K
|
| Net Income |
$58.52 M
|
$54.34 M
|
$62.04 M
|
$30.36 M
|
$65.77 M
|
$46.46 M
|
-$8.57 M
|
$661.00 K
|
-$12.45 M
|
| Net Income Ratio |
0.05
|
0.05
|
0.06
|
0.04
|
0.13
|
0.13
|
-0.04
|
0.01
|
-0.26
|
| EPS |
0.68 |
0.59 |
0.65 |
0.33 |
0.74 |
0.54 |
-0.1 |
0.0081 |
-2.19 |
| EPS Diluted |
0.65 |
0.57 |
0.62 |
0.3 |
0.66 |
0.47 |
-0.1 |
0.0081 |
-2.19 |
| Weighted Average Shares Out |
$85.23 M
|
$91.48 M
|
$95.02 M
|
$92.20 M
|
$89.11 M
|
$85.72 M
|
$83.57 M
|
$81.56 M
|
$5.69 M
|
| Weighted Average Shares Out Diluted |
$89.46 M
|
$95.45 M
|
$100.67 M
|
$99.96 M
|
$100.36 M
|
$99.06 M
|
$83.57 M
|
$81.56 M
|
$5.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
